济民健康(603222)今日涨停，全天换手率31.31%，成交额18.28亿元，振幅19.56%。龙虎榜数据显示， 营业部席位合计净买入6344.57万元。 上交所公开信息显示，当日该股因日振幅值达19.56%、日换手率达31.31%上榜，营业部席位合计净买 入6344.57万元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司总部 | 6791.60 | | | | 摩根大通证券(中国)有限公司上海银城中路证券营业部 | 5517.14 | | | 买三 | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券 营业部 | 3992.07 | | | 卖 买二 | | | | 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交4.08亿元，其中，买入成交额为2.36亿 元，卖出成交额为1.72亿元，合计净买入6344.57万元。 具体来看，今日上榜营业部中，第一大买入营业部为国泰海通证券股份有限公司总部，买入金额为 6791.60万元，第一大卖出营业部为浙商 ...

Core Viewpoint - Jimin Health (603222.SH) reported a significant decline in revenue and incurred losses in the first half of the year, primarily due to external factors and inventory adjustments [1] Financial Performance - The company achieved total operating revenue of 366.44 million yuan, a decrease of 21.30% compared to the same period last year [1] - The medical services segment generated revenue of 168.62 million yuan, down 4.80% year-on-year [1] - The medical device segment reported revenue of 75.10 million yuan, a substantial decline of 47.54% year-on-year [1] - The large-volume infusion segment earned revenue of 121.35 million yuan, reflecting a decrease of 15.50% year-on-year [1] Profitability - The company recorded a net loss attributable to shareholders of 52.70 million yuan and a net loss of 53.20 million yuan after excluding non-recurring gains and losses [1] - The losses were primarily attributed to the impact of U.S. tariff policies and the "He Qinghong stamp incident," which significantly reduced revenue and profits from medical devices [1] - Additionally, the company increased inventory write-down provisions for pre-filled catheter flushing devices and safety syringes based on market sales conditions [1]

济民健康管理股份有限公司2025 年半年度报告 公司代码：603222 公司简称：济民健康 济民健康管理股份有限公司 2025 年半年度报告 1 / 155 济民健康管理股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人李丽莎、主管会计工作负责人杨国伟及会计机构负责人（会计主管人员）王合 微声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 报告期，公司不进行利润分配及资本公积转增股本。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺，敬 请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的 ...

济民健康公告，2025年上半年营业收入3.66亿元，同比下降21.30%。净利润亏损5269.59万元，上年同 期净利润2544.5万元。报告期，公司不进行利润分配及资本公积转增股本。 ...

证券之星消息，8月20日医疗器械板块较上一交易日上涨0.06%，济民健康领涨。当日上证指数报收于 3766.21，上涨1.04%。深证成指报收于11926.74，上涨0.89%。医疗器械板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603222 | 济民健康 | 11.86 | 10.02% | 164.39万 | | 18.28亿 | | 300642 | 透景生命 | 24.81 | 7.45% | 35.17万 | | 8.65 Z | | 688581 | 安杰思 | 87.93 | 6.07% | 2.57万 | | 2.20亿 | | 301093 | 华兰股份 | 34.04 | 4.58% | 13.19万 | | 4.45亿 | | 600645 | 中源协和 | 29.66 | 3.27% | 23.37万 | | ...

Group 1 - The A-share market saw a total of 104 stocks hitting the daily limit up on August 20, with notable performances in various sectors [1][2] - Jimin Health in the medical device sector achieved a five-day consecutive limit up, indicating strong investor interest [1] - Other sectors with significant performances included consumer electronics with Kosen Technology achieving four consecutive limit ups, and the liquor sector with both Jiugui Liquor and *ST Yanshi achieving two consecutive limit ups [1][2] Group 2 - The list of stocks with consecutive limit ups includes: - Jimin Health (5 days, Medical Devices) - Kosen Technology (4 days, Consumer Electronics) - Hanzhong Precision (4 days, Data Center) - Jiugui Liquor (2 days, Liquor) - *ST Yanshi (2 days, Liquor) [1][2]

Group 1 - The Science and Technology Innovation 50 Index rose over 3%, reaching a new high for the year, driven by a collective surge in chip stocks [1] - Companies such as Jimin Health, Hanzhong Precision Machinery, and Kesen Technology have seen consecutive trading gains, with Jimin Health achieving a five-day streak [1] - The AI server market is dominated by Inspur Information, which holds over 50% market share in China and has reported a 64.39% year-on-year increase in net profit for the first quarter [1] Group 2 - The domestic leading companies are making significant advancements, with Nvidia reportedly developing an AI chip specifically for the Chinese market [3] - Companies like Fullchai Power and Yuanlin Co. have also seen consecutive trading gains, indicating strong market performance [3] - The company Guangxin Technology is a leader in optical modules and has partnered with Cisco to launch a 1.6T silicon optical module [3] Group 3 - The domestic automotive sector is witnessing significant developments, with China FAW planning to acquire approximately 10% of Leap Motor [6] - Companies like Mould Technology and Shentong Express are also making strides, with Mould Technology providing components for new energy vehicles [6] - The automotive thermal management sector is led by companies like Hanzhong Precision Machinery, which specializes in compressors and refrigeration products [8] Group 4 - The pharmaceutical industry is seeing a surge in domestic innovative drugs going global, with Tianmu Pharmaceutical being the first listed company in traditional Chinese medicine [7] - Companies like Huahai Pharmaceutical are advancing in the development of innovative drugs, with over 20 projects currently in research [7] - The automotive passive safety system sector is represented by companies like Songyuan Safety, which reported a 30.85% year-on-year increase in net profit [7]

Group 1 - The medical device sector experienced fluctuations, with the medical device ETF (562600) declining by 0.21%. However, Ji Min Health saw a strong surge, hitting the daily limit for five consecutive trading days, while Tuo Jing Life and An Jie Si also rose by over 6% [1] - In terms of capital flow, the medical device ETF (562600) had net inflows for four out of the last five trading days, accumulating 42.82 million yuan, and nine out of the last ten trading days, totaling 68.02 million yuan [1] - The recently released "Implementation Opinions on Promoting the Innovation and Development of Brain-Machine Interface Industry" aims for breakthroughs in key technologies by 2027, establishing advanced technical, industrial, and standard systems [1] Group 2 - The implementation opinions emphasize increased support for key products like implantable brain-machine interface medical devices, including expedited registration guidance and priority support [1] - According to Xinda Securities, the centralized procurement in the medical device sector is changing the competitive landscape, benefiting leading companies and accelerating domestic substitution [1] - The medical device industry is expected to transition from scale expansion to a higher level of development, with opportunities arising from technological platformization, AI diagnostics, and consumer healthcare extensions [1] Group 3 - The medical device ETF (562600) serves as a convenient tool for investors to capture growth opportunities in the medical device industry, tracking the CSI All Share Medical Device Index [2] - This ETF selects 100 representative listed companies in core medical fields, with the medical device sector accounting for 89.34% of the index, highlighting its concentrated structure [2]

龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%、日涨幅偏离值达7%上榜龙虎榜2 次，买卖居前营业部中，机构净买入3375.02万元，营业部席位合计净卖出5398.04万元。 4月29日公司发布的一季报数据显示，一季度公司共实现营业总收入1.81亿元，同比下降22.49%，实现 净利润-0.14亿元，同比下降191.72%。7月12日公司公布了上半年业绩预告，预计实现净利润-0.55亿元 至-0.46亿元。（数据宝） 近日该股表现 （文章来源：证券时报网） 济民健康盘中涨停，已连收5个涨停板，截至14:41，该股报11.86元，换手率30.89%，成交量1.62亿股， 成交金额18.02亿元，涨停板封单金额为1.16亿元。连续涨停期间，该股累计上涨61.14%，累计换手率 为81.14%。最新A股总市值达62.28亿元。 证券时报·数据宝统计，两融数据来看，该股最新（8月19日）两融余额为2.18亿元，其中，融资余额 2.18亿元，较前一个交易日增加357.17万元，环比增长1.67%，近5日累计增加5577.80万元，环比增长 34.49%。 | 日期 | 当日涨跌幅（%） | 换手率（%） ...

Market Overview - Major market indices opened lower, with the Shanghai Composite Index down 0.28% at 3716.68 points, the Shenzhen Component Index down 0.61% at 11749.99 points, and the ChiNext Index down 1.14% at 2572.01 points [1]. Stock Performance - A total of 1167 stocks rose at the opening, with newly listed stock N Hongyuan surging 305.67% at the open. There were 9 stocks hitting the daily limit up, including *ST Aowei with 11 consecutive limit ups, Kosen Technology with 4 consecutive limit ups, and ST Dongshi with 3 limit ups in 4 days [1]. - Conversely, 3502 stocks opened lower, with 2 stocks, *ST Gaohong and *ST Nanzhi, hitting the daily limit down [1]. Price Continuity - Among the stocks that hit the limit up yesterday, those that continued to hit the limit up today included Kosen Technology and Shimao Energy, totaling 6 stocks. Stocks that opened lower included Zhongheng Electric, Haili Shares, and Jimin Health, with declines of 8.29%, 5.52%, and 5.19% respectively [1]. - Stocks that hit the limit down yesterday and continued to do so today included *ST Gaohong and *ST Nanzhi [1].